2m 2m 2m 2m 2m 2m 2m
BETA BIONICS (BBNX)
NASDAQ
$16.64-$0.31 (-1.86%)
Price as of Jul 14, 2026 4:01 AM EDT- $758.9MMarket Cap
- 32.11%1-Year Change
- Medical DevicesIndustry
BETA BIONICS (BBNX)
$16.64-$0.31 (-1.86%)
BBNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.95 | ||
Change | -$0.08 (-0.47%) | ||
Open | $17.10 | ||
High | $17.52 | ||
Low | $16.43 | ||
Previous Close | $17.03 | ||
Volume | 1,015,548 | ||
30-Day Average Volume | 1,000,118 | ||
1-Week Change | 1.38% | ||
1-Month Change | 16.66% | ||
1-Year Change | 32.11% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.6M | ||
Total Assets | $304.4M | ||
Market Cap | $758.9M | ||
Enterprise Value | $728.7M | ||
Period: QTR TTM FY | |||
Revenue | $27.6M | ||
Net Income | -$21.9M | ||
Free Cash Flow | -$25.2M | ||
EBIT | -$21.9M | ||
EBITDA | -$21.3M | ||
Net Working Capital | $224.8M | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 3 | ||
P/E | -35 | ||
PEG | 1 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue